SEARCH

SEARCH BY CITATION

References

  • 1
    Pandolfino JE, Schriener MA, Lee TJ, Zhang Q, Boniquit C, Kahrilas PJ. Comparison of the BravoTM wireless and DigitrapperTM cathete-based monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol 2005; 100: 146676.
    Direct Link:
  • 2
    Gardner JD, Rodriguez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of GERD. Am J Gastroenterol 2001; 96: 136370.
    Direct Link:
  • 3
    Gardner JD, Perdomo C, Sloan S, et al. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther 2002; 16: 45564.
  • 4
    Gardner JD, Sloan S, Miner PB Jr, Robinson M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17: 94553.
  • 5
    Gardner JD, Sloan S, Miner PB Jr, Robinson M. Determination of the reduction in gastric acidity necessary to prevent pathologic esophageal reflux in GERD patients treated with a proton pump inhibitor. Aliment Pharmacol Ther 2003; 17: 95564.
  • 6
    Gardner JD, Sloan S, Robinson M, Miner PB Jr. Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux patients treated with a proton pump inhibitor. Aliment Pharmacol Ther 2003; 18: 13340.
  • 7
    Gardner JD, Gallo-Torres H, Sloan S, Robinson M, Miner PB Jr. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Aliment Pharmacol Ther 2003; 18: 891905.
  • 8
    Polygram Function Testing Software for Windows. EsopHogramTM Reflux Analysis Module, Version 2.01. Reference Manual, US Edition. Shoreview, MN: Synectics Medical AB, 19941997.
  • 9
    Miner P Jr, Katz PO, Chen Y, Sostek M. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003; 98: 261620.
    Direct Link:
  • 10
    Williams MP, Sercombe J, Hamilton MI, Pounder RE. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole vs. omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998; 12: 107989.